Arketamine, a new rapid-acting antidepressant: A historical review and future directions
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Arketamine, a new rapid-acting antidepressant: A historical review and future directions
Authors
Keywords
-
Journal
NEUROPHARMACOLOGY
Volume 218, Issue -, Pages 109219
Publisher
Elsevier BV
Online
2022-08-15
DOI
10.1016/j.neuropharm.2022.109219
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Brain Research Bulletin Special Issue: Brain–body communication in health and diseases Brain–spleen axis in health and diseases: a review and future perspective
- (2022) Yan Wei et al. BRAIN RESEARCH BULLETIN
- N,N‐dimethyltryptamine and Amazonian ayahuasca plant medicine
- (2022) Edward James et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Mechanisms of action of fluvoxamine for COVID-19: a historical review
- (2022) Yaeko Hashimoto et al. MOLECULAR PSYCHIATRY
- Assessing the risk–benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research
- (2022) David Bender et al. PSYCHOPHARMACOLOGY
- An Update on Community Ketamine Practices
- (2022) Brittany O’Brien et al. AMERICAN JOURNAL OF PSYCHIATRY
- Is (R)-ketamine a potential therapeutic agent for treatment-resistant depression with less detrimental side effects? A review of molecular mechanisms underlying ketamine and its enantiomers
- (2022) Ellen Scotton et al. BIOCHEMICAL PHARMACOLOGY
- Brain–gut–microbiota axis in depression: A historical overview and future directions
- (2022) Lijia Chang et al. BRAIN RESEARCH BULLETIN
- Ketamine: anesthetic, psychotomimetic, antidepressant, or anthelmintic?
- (2022) Kenji Hashimoto MOLECULAR PSYCHIATRY
- The promises and perils of psychedelic pharmacology for psychiatry
- (2022) Tristan D. McClure-Begley et al. NATURE REVIEWS DRUG DISCOVERY
- (R)-ketamine ameliorates demyelination and facilitates remyelination in cuprizone-treated mice: A role of gut–microbiota–brain axis
- (2022) Xingming Wang et al. NEUROBIOLOGY OF DISEASE
- Suppression of abnormal α-synuclein expression by activation of BDNF transcription ameliorates Parkinson’s disease-like pathology
- (2022) Qianqian Cao et al. Molecular Therapy-Nucleic Acids
- Regulation of BDNF transcription by Nrf2 and MeCP2 ameliorates MPTP-induced neurotoxicity
- (2022) Qianqian Cao et al. Cell Death Discovery
- Blood miR-144-3p: a novel diagnostic and therapeutic tool for depression
- (2022) Yentl Y. van der Zee et al. MOLECULAR PSYCHIATRY
- Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis
- (2022) Gustavo C. Medeiros et al. MOLECULAR PSYCHIATRY
- The role of hippocampal KCNQ2 channel in antidepressant actions of ketamine
- (2022) Li Ma et al. NEURON
- Ketamine exerts its sustained antidepressant effects via cell-type-specific regulation of Kcnq2
- (2022) Juan Pablo Lopez et al. NEURON
- Effects of (R)-ketamine on reduced bone mineral density in ovariectomized mice: A role of gut microbiota
- (2022) Xiayun Wan et al. NEUROPHARMACOLOGY
- (R)-ketamine as prophylactic and therapeutic drug for neurological disorders: Beyond depression
- (2022) Xingming Wang et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- New antidepressants: New day or false dawn?
- (2022) Luke A. Jelen et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Mapping consent practices for outpatient psychiatric use of ketamine
- (2022) David S. Mathai et al. JOURNAL OF AFFECTIVE DISORDERS
- Ketamine; history and role in anesthetic pharmacology
- (2022) Kazuyoshi Hirota et al. NEUROPHARMACOLOGY
- The opioid system in depression
- (2022) Luke A. Jelen et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder
- (2021) Adriana Feder et al. AMERICAN JOURNAL OF PSYCHIATRY
- Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptor
- (2021) Kenji Hashimoto EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Improving Suicide Prevention Through Evidence-Based Strategies: A Systematic Review
- (2021) J. John Mann et al. AMERICAN JOURNAL OF PSYCHIATRY
- Impact of the KCNQ2/3 Channel Opener Ezogabine on Reward Circuit Activity and Clinical Symptoms in Depression: Results From a Randomized Controlled Trial
- (2021) Sara Costi et al. AMERICAN JOURNAL OF PSYCHIATRY
- Flexible Stoichiometry: Implications for KCNQ2- and KCNQ3-Associated Neurodevelopmental Disorders
- (2021) Kristen Springer et al. DEVELOPMENTAL NEUROSCIENCE
- Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor
- (2021) Yan Wei et al. MOLECULAR PSYCHIATRY
- Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability
- (2021) Jordi Bonaventura et al. MOLECULAR PSYCHIATRY
- Short DNA/RNA heteroduplex oligonucleotide interacting proteins are key regulators of target gene silencing
- (2021) Ken Asada et al. NUCLEIC ACIDS RESEARCH
- Intranasal administration of transforming growth factor-β1 elicits rapid-acting antidepressant-like effects in a chronic social defeat stress model: A role of TrkB signaling
- (2021) Yan Wei et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- (R)-Ketamine attenuates LPS-induced endotoxin-derived delirium through inhibition of neuroinflammation
- (2021) Jiancheng Zhang et al. PSYCHOPHARMACOLOGY
- The effectiveness of (R)-ketamine and its mechanism of action differ from those of (S)-ketamine in a chronic unpredictable mild stress model of depression in C57BL/6J mice
- (2021) Anna Rafało-Ulińska et al. BEHAVIOURAL BRAIN RESEARCH
- (R)-ketamine ameliorates the progression of experimental autoimmune encephalomyelitis in mice
- (2021) Xingming Wang et al. BRAIN RESEARCH BULLETIN
- (R)-Ketamine ameliorates lethal inflammatory responses and multi-organ injury in mice induced by cecum ligation and puncture
- (2021) Jiancheng Zhang et al. LIFE SCIENCES
- Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine
- (2021) Wei Yao et al. MOLECULAR PSYCHIATRY
- Revisiting the sigma-1 receptor as a biological target to treat affective and cognitive disorders
- (2021) Kinga Sałaciak et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Mechanisms of ketamine and its metabolites as antidepressants
- (2021) Evan M. Hess et al. BIOCHEMICAL PHARMACOLOGY
- Intravenous arketamine for treatment-resistant depression: open-label pilot study
- (2020) Gustavo C. Leal et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- CREB Family Transcription Factors Are Major Mediators of BDNF Transcriptional Autoregulation in Cortical Neurons
- (2020) Eli-Eelika Esvald et al. JOURNAL OF NEUROSCIENCE
- A historical review of antidepressant effects of ketamine and its enantiomers
- (2020) Yan Wei et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Essential role of microglial transforming growth factor-β1 in antidepressant actions of (R)-ketamine and the novel antidepressant TGF-β1
- (2020) Kai Zhang et al. Translational Psychiatry
- Risk of psychosis after repeated intermittent administration of (S)-ketamine, but not (R)-ketamine, in mice
- (2020) Yunfei Tan et al. JOURNAL OF AFFECTIVE DISORDERS
- Are NMDA and opioid receptors involved in the antidepressant actions of ketamine?
- (2020) Kenji Hashimoto PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine
- (2020) Kenji Hashimoto BIOCHEMICAL PHARMACOLOGY
- Assessment of Ketamine and its Enantiomers in an Organophosphate-Based Rat Model for Features of Gulf War Illness
- (2020) Jackie Zhu et al. International Journal of Environmental Research and Public Health
- Chaperone Sigma1R and Antidepressant Effect
- (2020) Mikhail V. Voronin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Recent advances in the antidepressant actions of ketamine and agents having ketamine-like antidepressant profiles
- (2020) Shigeyuki Chaki PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Ketamine: A Paradigm Shift for Depression Research and Treatment
- (2019) John H. Krystal et al. NEURON
- The ERK Pathway: Molecular Mechanisms and Treatment of Depression
- (2019) John Q. Wang et al. MOLECULAR NEUROBIOLOGY
- Antiepileptic therapy approaches in KCNQ2 related epilepsy: A systematic review
- (2019) M. Kuersten et al. European Journal of Medical Genetics
- Esketamine for Treatment-Resistant Depression — First FDA-Approved Antidepressant in a New Class
- (2019) Jean Kim et al. NEW ENGLAND JOURNAL OF MEDICINE
- Highly efficient silencing of microRNA by heteroduplex oligonucleotides
- (2019) Kotaro Yoshioka et al. NUCLEIC ACIDS RESEARCH
- Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine
- (2019) Lijia Chang et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective
- (2019) Kenji Hashimoto PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism
- (2019) Nolan R. Williams et al. MOLECULAR PSYCHIATRY
- MPTP-induced dopaminergic neurotoxicity in mouse brain is attenuated after subsequent intranasal administration of (R)-ketamine: a role of TrkB signaling
- (2019) Atsuhiro Fujita et al. PSYCHOPHARMACOLOGY
- (R)‐ and (S)‐ketamine induce differential fMRI responses in conscious rats
- (2019) Yukiko Masaki et al. SYNAPSE
- Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites
- (2019) Chun Yang et al. Translational Psychiatry
- Splenic NKG2D confers resilience versus susceptibility in mice after chronic social defeat stress: beneficial effects of (R)-ketamine
- (2019) Kai Zhang et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial
- (2018) Michael F. Grunebaum et al. AMERICAN JOURNAL OF PSYCHIATRY
- The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis
- (2018) Samuel T. Wilkinson et al. AMERICAN JOURNAL OF PSYCHIATRY
- Mechanistic Target of Rapamycin–Independent Antidepressant Effects of ( R )-Ketamine in a Social Defeat Stress Model
- (2018) Chun Yang et al. BIOLOGICAL PSYCHIATRY
- AMPA Receptor Activation–Independent Antidepressant Actions of Ketamine Metabolite ( S )-Norketamine
- (2018) Chun Yang et al. BIOLOGICAL PSYCHIATRY
- What Are the Causes for Discrepancies of Antidepressant Actions of (2 R ,6 R )-Hydroxynorketamine?
- (2018) Kenji Hashimoto et al. BIOLOGICAL PSYCHIATRY
- Is (S)-norketamine an alternative antidepressant for esketamine?
- (2018) Kenji Hashimoto et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
- (2018) Panos Zanos et al. PHARMACOLOGICAL REVIEWS
- Expression of heat shock protein HSP-70 in the retrosplenial cortex of rat brain after administration of ( R,S )-ketamine and ( S )-ketamine, but not ( R )-ketamine
- (2018) Zheng Tian et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism
- (2018) Nolan R. Williams et al. AMERICAN JOURNAL OF PSYCHIATRY
- Lack of Opioid System in the Antidepressant Actions of Ketamine
- (2018) Kai Zhang et al. BIOLOGICAL PSYCHIATRY
- An update on ketamine and its two enantiomers as rapid-acting antidepressants
- (2018) Kai Zhang et al. Expert Review of Neurotherapeutics
- Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
- (2018) Maurizio Fava et al. MOLECULAR PSYCHIATRY
- Antidepressant Potential of ( R )-Ketamine in Rodent Models: Comparison with ( S )-Ketamine
- (2017) Kenichi Fukumoto et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression
- (2017) Tung-Ping Su et al. NEUROPSYCHOPHARMACOLOGY
- Ketamine as a rapid-acting agent for suicidal ideation: A meta-analysis
- (2017) Francesco Bartoli et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection
- (2017) Shomyseh Sanjabi et al. Cold Spring Harbor Perspectives in Biology
- Comparison of (R)-ketamine and lanicemine on depression-like phenotype and abnormal composition of gut microbiota in a social defeat stress model
- (2017) Youge Qu et al. Scientific Reports
- Possible role of the gut microbiota–brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model
- (2017) Chun Yang et al. Translational Psychiatry
- Detrimental Side Effects of Repeated Ketamine Infusions in the Brain
- (2016) Kenji Hashimoto AMERICAN JOURNAL OF PSYCHIATRY
- Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets
- (2016) Ji-chun Zhang et al. Current Neuropharmacology
- Reduction of dopamine D2/3 receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys
- (2016) Kenji Hashimoto et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Ketamine’s antidepressant action: beyond NMDA receptor inhibition
- (2016) Kenji Hashimoto EXPERT OPINION ON THERAPEUTIC TARGETS
- Antidepressant Effects of (+)-MK-801 and (-)-MK-801 in the Social Defeat Stress Model
- (2016) Bangkun Yang et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- NMDAR inhibition-independent antidepressant actions of ketamine metabolites
- (2016) Panos Zanos et al. NATURE
- Loss of parvalbumin-immunoreactivity in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamine
- (2016) Chun Yang et al. PSYCHIATRY RESEARCH
- Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories
- (2016) T. Kishimoto et al. PSYCHOLOGICAL MEDICINE
- Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression
- (2015) D. Jeffrey Newport et al. AMERICAN JOURNAL OF PSYCHIATRY
- Activation of sigma-1 receptor chaperone in the treatment of neuropsychiatric diseases and its clinical implication
- (2015) Kenji Hashimoto JOURNAL OF PHARMACOLOGICAL SCIENCES
- Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial
- (2015) J. W. Murrough et al. PSYCHOLOGICAL MEDICINE
- DNA/RNA heteroduplex oligonucleotide for highly efficient gene silencing
- (2015) Kazutaka Nishina et al. Nature Communications
- R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
- (2015) C Yang et al. Translational Psychiatry
- A Positive Autoregulatory BDNF Feedback Loop via C/EBP Mediates Hippocampal Memory Consolidation
- (2014) D. Bambah-Mukku et al. JOURNAL OF NEUROSCIENCE
- Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder
- (2014) Adriana Feder et al. JAMA Psychiatry
- The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression
- (2014) Kenji Hashimoto Clinical Psychopharmacology and Neuroscience
- M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination
- (2013) Veronique E Miron et al. NATURE NEUROSCIENCE
- R (−)-ketamine shows greater potency and longer lasting antidepressant effects than S (+)-ketamine
- (2013) Ji-chun Zhang et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Sigma-1 receptor chaperone and brain-derived neurotrophic factor: Emerging links between cardiovascular disease and depression
- (2012) Kenji Hashimoto PROGRESS IN NEUROBIOLOGY
- Evaluation of sigma (σ) receptors in the antidepressant-like effects of ketamine in vitro and in vivo
- (2011) Matthew J. Robson et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
- (2011) Anita E. Autry et al. NATURE
- Taming the Ketamine Tiger
- (2010) Edward F. Domino ANESTHESIOLOGY
- A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
- (2010) Nancy Diazgranados et al. ARCHIVES OF GENERAL PSYCHIATRY
- Cognition and depression: the effects of fluvoxamine, a sigma-1 receptor agonist, reconsidered
- (2010) Ian Hindmarch et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Brain-derived neurotrophic factor as a biomarker for mood disorders: An historical overview and future directions
- (2010) Kenji Hashimoto PSYCHIATRY AND CLINICAL NEUROSCIENCES
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
- (2010) N. Li et al. SCIENCE
- The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory
- (2003) J. David Sweatt JOURNAL OF NEUROCHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now